Zinc Acetate

CHEMBL3184986 Phase 4 Disetujui Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

183.5 g/mol

LogP

—

Phase

4

Zinc acetate is a zinc salt used therapeutically for Wilson's disease, a copper metabolism disorder, where orally administered zinc ions competitively inhibit intestinal copper absorption by inducing enterocyte metallothionein that sequesters copper and prevents its transfer to portal blood. It is also used as a dietary zinc supplement to treat or prevent zinc deficiency, supporting immune function, wound healing, and neurological function. Zinc acetate is preferred for maintenance therapy of Wilson's disease due to its favorable safety profile.

Berat Molekul

183,5000 g/mol

TPSA

80,30 Å²

Area Terapeutik

Epilepsy Generalized Anxiety Disorder Type 2 Diabetes HIV/AIDS Heart Failure

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(=O)[O-].CC(=O)[O-].O.O.[Zn+2]

InChI

InChI=1S/2C2H4O2.2H2O.Zn/c2*1-2(3)4;;;/h2*1H3,(H,3,4);2*1H2;/q;;;;+2/p-2

Molecular Formula

C4H6O4Zn

HBD / HBA

- / 4

Ikatan yang Dapat Dirotasi

0

Atom Berat

9

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

Zinc acetate is a zinc salt used therapeutically for Wilson's disease, a copper metabolism disorder, where orally administered zinc ions competitively inhibit intestinal copper absorption by inducing enterocyte metallothionein that sequesters copper and prevents its transfer to portal blood. It is also used as a dietary zinc supplement to treat or prevent zinc deficiency, supporting immune function, wound healing, and neurological function. Zinc acetate is preferred for maintenance therapy of Wilson's disease due to its favorable safety profile.

Yes, Zinc Acetate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3184986. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 11192. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Mencari informasi yang ramah bagi pasien?

Zinc Acetate di PillFYI

Struktur

Data Cepat

Rumus: C4H6O4Zn
Sinonim: 196

Tautan Eksternal

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.